You are here:Home1/casestudy2/CORD:USE has been acquired by Cryo-Cell International
CORD:USE has been acquired by Cryo-Cell International
Background: CORD:USE Cord Blood Bank (“Cord”), based in Orlando, FL, owns and operates a cord blood bank that focuses on building an inventory of umbilical cord blood stem cell units for patients in need of a life-saving transplant.
Cassel Salpeter:
Served as financial advisor to the Company
Advised Cord in evaluating its strategic options and provided assistance throughout the due diligence and closing process
Ran a broad sales process, contacting 115 parties
Challenges:
Small footprint – Marketing in select markets
Sizeable amount of debt
Complex capital structure
Outcome: In June 2018, Cord was acquired by Cryo-Cell International, Inc. The upfront consideration consisted of cash and shares of Common Stock with the potential for contingency cash payments based upon pre-determined milestones.
https://www.casselsalpeter.com/wp-content/uploads/2024/05/CS_Website-Case-Study-Logos_05.03.24_CORDUSE.jpg321385roaradminhttps://www.casselsalpeter.com/wp-content/uploads/2025/04/CasselSalpeter_15th-Anniversary-Logo_Website-Header_1112-x305_Option-2-1030x283.pngroaradmin2018-06-01 17:29:412024-05-03 18:07:45CORD:USE has been acquired by Cryo-Cell International
